The SURMOUNT clinical trial program provides robust evidence for Zepbound's sustained effectiveness over extended treatment periods
Risks Of Medication Instability And Contamination Tirzepatide is typically administered in special pens or vials
Discuss options with your prescribing provider and compounding pharmacy to determine which formulation aligns with your health goals
For context, most telehealth providers in this space hover between 3.5 and 4.5 stars
Reported incidences in those receiving a 12mg/weekly dose of retatrutide were [21]: Nausea (45% of participants) Vomiting (19%) Constipation (16%) Diarrhea (15%) Cardiac arrhythmia (11%) Fatigue (10%) Increased pancreatic enzyme (lipase) levels (8%) Injection site reactions (8%) Liver issues in 2 participants (3%) Pancreatitis in 1 participant (2%) Both tirzepatide and retatrutide share similar contraindications, including advice against their use during pregnancy and breastfeeding
Regular medication reviews, ideally every 36 months, allow for assessment of treatment efficacy, tolerability, and ongoing appropriateness of therapy in line with NICE guidance on diabetes management (NG28)
